Last Updated: 09/21/23
Leukemia SPOREs
While major advances in leukemia diagnosis and treatment were achieved in the last 50 years, especially in childhood leukemia, this group of diseases remains a very serious medical problem. According to the NCI's Surveillance, Epidemiology, and End Results Program (SEER) statistical data, it is estimated that in 2023 there will be a total of 59,610 new cases of leukemia in the U.S., and that 23,700 people will die of this disease. In 2019, the average annual incidence rate of leukemia in the United States was 13.1 per 100,000, and the average annual observed death rate was 5.9. The first round of SPORE applications in leukemia took place in 2002, with the subsequent award of the first Leukemia SPORE in 2003.